Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy
Bacterial resistance to known and currently used antibiotics represents a growing issue worldwide. It poses a major problem in the treatment of infectious diseases in general and hospital-acquired infections in particular. This is in part due to the overuse and misuse of antibiotics in past decades,...
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (206 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545059104498 |
|---|---|
| ctrlnum |
(CKB)5690000000011961 (oapen)https://directory.doabooks.org/handle/20.500.12854/87484 (EXLCZ)995690000000011961 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Bostik, Pavel edt Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy Hospital Acquired Infections, Multidrug Resistant Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (206 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Bacterial resistance to known and currently used antibiotics represents a growing issue worldwide. It poses a major problem in the treatment of infectious diseases in general and hospital-acquired infections in particular. This is in part due to the overuse and misuse of antibiotics in past decades, which led to the selection of highly resistant bacteria and even so-called superbugs – multidrug-resistant (MDR) bacteria. Nosocomial infections, particularly, are often caused by MDR bacterial pathogens and the treatment of such infections is very complicated and extensive, often leading to various side effects, including adverse effects on the natural human microbiome. At the same time, the development of novel antibiotics is lagging with very few new ones in the pipeline. Finding viable alternatives to treat such infections may help to overcome these therapeutic issues. This publication brings novel developments in the field of bacterial resistance, mainly in the hospital settings, adequate antibiotic therapy, and identification of compounds useful to battle this growing issue. English Medicine bicssc Epidemiology & medical statistics bicssc VRE GIT hemato-oncological patients clonality antibiotic stewardship resistance consumption of antibiotics clonal spread Enterococcus faecium Enterococcus faecalis linezolid resistance 23S rRNA optrA carbapenem-resistant Klebsiella pneumoniae carbapenem-resistant Acinetobacter baumannii N-acetylcysteine septic shock critically ill patients newborn infection bacteria antibiotic therapy hops C. difficile rat model Staphylococcus aureus MRSA spa typing MLST SCCmec typing clonal analysis epidemiology cancer patients duration of treatment colistin propensity score analysis multidrug-resistant Acinetobacter baumannii urinary tract infections UTIs MDR Escherichia coli Klebsiella uropathogens AMR antibiotic resistance ESBL-producing Klebsiella pneumoniae urinary tract infection clinical impact economic impact ventilator-associated pneumonia Klebsiella spp. Escherichia spp. pulsed-field gel electrophoresis (PFGE) endogenous infection methicillin-resistant porcine model methicillin-resistant Staphylococcus aureus (MRSA) long term care facilities (LTCF) multidrug resistance (MDR) enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) ESBL PCR primer antimicrobial resistance infection prevention and control antimicrobial stewardship hospital cluster analysis principal component analysis 3-0365-4418-6 3-0365-4417-8 Kolar, Milan edt Bostik, Pavel oth Kolar, Milan oth |
| language |
English |
| format |
eBook |
| author2 |
Kolar, Milan Bostik, Pavel Kolar, Milan |
| author_facet |
Kolar, Milan Bostik, Pavel Kolar, Milan |
| author2_variant |
p b pb m k mk |
| author2_role |
HerausgeberIn Sonstige Sonstige |
| title |
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy |
| spellingShingle |
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy |
| title_full |
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy |
| title_fullStr |
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy |
| title_full_unstemmed |
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy |
| title_auth |
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy |
| title_alt |
Hospital Acquired Infections, Multidrug Resistant |
| title_new |
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy |
| title_sort |
hospital acquired infections, multidrug resistant (mdr) bacteria, alternative approaches to antibiotic therapy |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2022 |
| physical |
1 electronic resource (206 p.) |
| isbn |
3-0365-4418-6 3-0365-4417-8 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT bostikpavel hospitalacquiredinfectionsmultidrugresistantmdrbacteriaalternativeapproachestoantibiotictherapy AT kolarmilan hospitalacquiredinfectionsmultidrugresistantmdrbacteriaalternativeapproachestoantibiotictherapy AT bostikpavel hospitalacquiredinfectionsmultidrugresistant AT kolarmilan hospitalacquiredinfectionsmultidrugresistant |
| status_str |
n |
| ids_txt_mv |
(CKB)5690000000011961 (oapen)https://directory.doabooks.org/handle/20.500.12854/87484 (EXLCZ)995690000000011961 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy |
| author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
| _version_ |
1796652254928830464 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04663nam-a2201165z--4500</leader><controlfield tag="001">993545059104498</controlfield><controlfield tag="005">20231214133528.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202207s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5690000000011961</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/87484</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995690000000011961</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bostik, Pavel</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hospital Acquired Infections, Multidrug Resistant (MDR) Bacteria, Alternative Approaches to Antibiotic Therapy</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Hospital Acquired Infections, Multidrug Resistant </subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (206 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Bacterial resistance to known and currently used antibiotics represents a growing issue worldwide. It poses a major problem in the treatment of infectious diseases in general and hospital-acquired infections in particular. This is in part due to the overuse and misuse of antibiotics in past decades, which led to the selection of highly resistant bacteria and even so-called superbugs – multidrug-resistant (MDR) bacteria. Nosocomial infections, particularly, are often caused by MDR bacterial pathogens and the treatment of such infections is very complicated and extensive, often leading to various side effects, including adverse effects on the natural human microbiome. At the same time, the development of novel antibiotics is lagging with very few new ones in the pipeline. Finding viable alternatives to treat such infections may help to overcome these therapeutic issues. This publication brings novel developments in the field of bacterial resistance, mainly in the hospital settings, adequate antibiotic therapy, and identification of compounds useful to battle this growing issue.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epidemiology & medical statistics</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VRE</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GIT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hemato-oncological patients</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clonality</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic stewardship</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">consumption of antibiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clonal spread</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Enterococcus faecium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Enterococcus faecalis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">linezolid resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">23S rRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">optrA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbapenem-resistant Klebsiella pneumoniae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbapenem-resistant Acinetobacter baumannii</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">N-acetylcysteine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">septic shock</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">critically ill patients</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">newborn</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hops</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">C. difficile</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rat model</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Staphylococcus aureus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MRSA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spa typing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MLST</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SCCmec typing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clonal analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epidemiology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer patients</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">duration of treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colistin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">propensity score analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multidrug-resistant Acinetobacter baumannii</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urinary tract infections</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">UTIs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MDR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Escherichia coli</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Klebsiella</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uropathogens</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AMR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ESBL-producing Klebsiella pneumoniae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urinary tract infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical impact</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">economic impact</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ventilator-associated pneumonia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Klebsiella spp.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Escherichia spp.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pulsed-field gel electrophoresis (PFGE)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endogenous infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methicillin-resistant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">porcine model</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methicillin-resistant Staphylococcus aureus (MRSA)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long term care facilities (LTCF)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multidrug resistance (MDR)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ESBL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PCR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">primer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infection prevention and control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial stewardship</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hospital</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cluster analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">principal component analysis</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-4418-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-4417-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kolar, Milan</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bostik, Pavel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kolar, Milan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:56:52 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-07-14 08:50:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337820320004498&Force_direct=true</subfield><subfield code="Z">5337820320004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337820320004498</subfield></datafield></record></collection> |